What labs and tests are recommended for patients presenting with kidney stones?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Evaluation for Kidney Stones

All patients newly diagnosed with kidney stones should undergo a screening evaluation consisting of serum chemistries (electrolytes, calcium, creatinine, uric acid), urinalysis with microscopic examination, and stone analysis when available. 1, 2

Initial Laboratory Testing (All Patients)

Serum Studies

  • Electrolytes, calcium, creatinine, and uric acid are essential to identify underlying metabolic conditions such as hyperparathyroidism, renal tubular acidosis, or hyperuricemia that predispose to stone formation 1, 2
  • Serum intact parathyroid hormone (PTH) should be obtained if primary hyperparathyroidism is suspected, particularly when serum calcium is high or high-normal 3

Urinalysis

  • Both dipstick and microscopic evaluation are required to assess urine pH (which helps predict stone type), detect infection indicators, and identify pathognomonic crystals 1, 2
  • Urine culture is indicated if urinalysis suggests infection or if the patient has recurrent UTIs 1, 2

Stone Analysis

  • Send all available stone material for compositional analysis to determine stone type (calcium oxalate, calcium phosphate, uric acid, struvite, or cystine) and guide targeted prevention strategies 2, 3
  • Stone analysis should be performed at least once for all first-time stone formers and repeated in patients not responding to treatment, as composition may change over time 2, 3

Comprehensive Metabolic Evaluation (High-Risk Patients)

A 24-hour urine collection is recommended for all recurrent stone formers and high-risk first-time stone formers (those with family history, solitary kidney, malabsorption, intestinal disease, early-onset disease ≤25 years, or bilateral stones). 2, 3, 4

24-Hour Urine Parameters

The collection should analyze at minimum:

  • Total urine volume (assesses hydration status) 2, 3
  • Urine pH (acidic favors uric acid stones; alkaline favors calcium phosphate) 2, 3
  • Calcium, oxalate, uric acid, citrate (primary lithogenic factors) 2, 3
  • Sodium, potassium, creatinine (validates collection adequacy and assesses dietary factors) 2, 3

Additional Specialized Testing

  • Urinary cystine should be measured in patients with known cystine stones, family history of cystinuria, or suspected cystinuria 2, 3
  • Primary hyperoxaluria should be suspected when urinary oxalate exceeds 75 mg/day in adults without bowel dysfunction 2, 5
  • Two 24-hour collections are preferred over one for improved accuracy, though one collection may be adequate as studies show strong correlation between samples collected within 3 days 2, 5, 6

Imaging Studies

Initial Imaging

  • Ultrasound is recommended as the primary diagnostic tool (45% sensitivity for renal stones, 88% specificity), followed by non-contrast CT for definitive assessment 5, 3
  • Non-contrast CT is the gold standard for evaluating stone location, size, burden, and density (93.1% sensitivity, 96.6% specificity), with low-dose protocols preferred to minimize radiation 5, 3

Imaging Findings That Require Additional Workup

  • Multiple or bilateral renal calculi indicate higher recurrence risk and warrant comprehensive metabolic evaluation 3
  • Nephrocalcinosis suggests underlying metabolic disorders such as renal tubular acidosis or primary hyperparathyroidism 2, 3

Special Populations

Genetic Testing Considerations

Genetic testing should be considered in patients with early-onset stone disease (≤25 years), suspected inherited disorders, recurrent stones, bilateral disease, or strong family history 3

Persistent Microscopic Hematuria

  • 24-hour urine stone panel may be performed to assess for nephrolithiasis/microlithiasis 2
  • Additional testing may include cystoscopy and imaging to assess for urinary tract abnormalities or new stone formation 2

Common Pitfalls

  • Do not assume normal-sized kidneys on ultrasound exclude chronic kidney disease, as stone formers as a group have decreased renal function compared to normal individuals 5
  • Avoid delaying stone analysis until after discharge, as perioperative characterization provides valuable information about the urinary environment during stone formation, especially when only fragments are available 7
  • Do not skip metabolic evaluation in "low-risk" first-time stone formers if they express interest in prevention, as 24-hour urine analysis guides individualized dietary and pharmacologic interventions even when stones cannot be retrieved 2, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Laboratory Evaluation for Kidney Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Evaluation for Kidney Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Kidney Disease: Kidney Stones.

FP essentials, 2021

Guideline

Diagnostic Evaluation and Management of Kidney Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metabolic evaluation: who, when and how often.

Current opinion in urology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.